News & Updates

Show Multimedia Only

SC vs IV pembrolizumab: Which route is better for metastatic NSCLC?

30 Apr 2025 by

In patients with treatment-naive metastatic nonsmall cell lung cancer (NSCLC), subcutaneous (SC) pembrolizumab (pembro) demonstrates comparable efficacy to that of intravenous (IV) pembro as regards overall exposure and trough concentration, reports a study presented at ELCC 2025.

SC vs IV pembrolizumab: Which route is better for metastatic NSCLC?

30 Apr 2025

Neoadjuvant chemo plus durvalumab improves survival in NSCLC

30 Apr 2025 by

The addition of durvalumab to neoadjuvant chemotherapy with cisplatin and docetaxel results in better survival rates among patients with resectable nonsmall cell lung cancer (NSCLC), according to a study presented at ELCC 2025.

Neoadjuvant chemo plus durvalumab improves survival in NSCLC

30 Apr 2025

Pharmacists help prevent DDIs in patients taking NMV/r for COVID-19

29 Apr 2025

Clinically relevant drug–drug interactions (DDIs) are highly prevalent among oncohematology patients treated with nirmatrelvir/ritonavir (NMV/r) for COVID-19, reveals a study. Pharmacists have played an important role in detecting, categorizing, and mitigating these DDIs.

Pharmacists help prevent DDIs in patients taking NMV/r for COVID-19

29 Apr 2025

Community pharmacists ensure safe, effective use of OAMs

28 Apr 2025

Community pharmacists (CPs) are willing to implement oral anticancer medicine (OAM) interventions, which can potentially improve the management of patients with cancer, according to a cross-sectional study in France.

Community pharmacists ensure safe, effective use of OAMs

28 Apr 2025

How aware are HCPs about medication errors in oncology practice?

28 Apr 2025

The level of awareness regarding medication errors (MEs) is good to average among most healthcare professionals (HCPs) in a cancer hospital, reports a study.

How aware are HCPs about medication errors in oncology practice?

28 Apr 2025

Primary aldosteronism prevalent in PTC patients with hypertension

24 Apr 2025

Papillary thyroid cancer (PTC) in individuals with arterial hypertension is independently associated with a diagnosis of primary aldosteronism (PA), reports a study.

Primary aldosteronism prevalent in PTC patients with hypertension

24 Apr 2025

Novel urine test shows promise for kidney cancer recurrence surveillance

24 Apr 2025 by

The urine GAGome score appears to be a promising biomarker for detecting clear cell renal cell carcinoma (ccRCC) recurrence, findings from the AURORAX-0087A trial suggest.

Novel urine test shows promise for kidney cancer recurrence surveillance

24 Apr 2025

Add-on metformin of little benefit in advanced stage ovarian cancer

24 Apr 2025

Using metformin in addition to first-line platinum/taxane-based chemotherapy does not appear to produce survival gains in patients with newly diagnosed advanced stage ovarian cancer, according to a study.